Characterization of bortezomib-adapted I-45 mesothelioma cells

BACKGROUND: Bortezomib, a proteasome-specific inhibitor, has emerged as a promising cancer therapeutic agent. However, development of resistance to bortezomib may pose a challenge to effective anticancer therapy. Therefore, characterization of cellular mechanisms involved in bortezomib resistance an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang, Lidong, Littlejohn, James E, Cui, Yu, Cao, Xiaobo, Peddaboina, Chander, Smythe, W Roy
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2882347/
https://ncbi.nlm.nih.gov/pubmed/20482802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-110
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares